Interim Report on Origin of SARS-CoV-2 Scrapped by WHO
Interim Report on Origin of SARS-CoV-2 Scrapped by WHO
Instead, the full report will be available in mid-March.
Interim Report on Origin of SARS-CoV-2 Scrapped by WHO
Interim Report on Origin of SARS-CoV-2 Scrapped by WHO

Instead, the full report will be available in mid-March.

Instead, the full report will be available in mid-March.

scientific misconduct, immunology
Variant Found in Brazil Could Evade Immunity from Past Infection
Variant Found in Brazil Could Evade Immunity from Past Infection
Lisa Winter | Mar 2, 2021
The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.
Impact of Running Reaches Marrow to Spark Bone Growth in Mice
Impact of Running Reaches Marrow to Spark Bone Growth in Mice
Emma Yasinski | Mar 2, 2021
A study offers a new explanation for how exercise strengthens bones and the immune system.
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
Infographic: Envisioning Macrophages
Infographic: Envisioning Macrophages
Ashley Yeager | Mar 1, 2021
Researchers find different distributions of the immune cells in young, older, and diseased eyes.
Sex Differences in Immune Responses to Viral Infection
Sex Differences in Immune Responses to Viral Infection
Catherine Offord | Mar 1, 2021
Stronger interferon production, greater T cell activation, and increased susceptibility to autoimmunity are just some of the ways that females seem to differ from males.
Macrophages of the Human Eye Come into Focus
Macrophages of the Human Eye Come into Focus
Ashley Yeager | Mar 1, 2021
Imaged in real time in living people, immune cells at the surface of the retina could serve as biomarkers to detect retinal and possibly neurological diseases and track their progression.
Infographic: How SARS-CoV-2 Immune Responses May Differ by Sex
Infographic: How SARS-CoV-2 Immune Responses May Differ by Sex
Catherine Offord | Mar 1, 2021
Males and females show differences in gene expression, cell activation, and antibody production in response to some viral infections, but whether these influence COVID-19 outcomes is still unclear.
Q&A: New Trials Tackle COVID-19 Vaccines in Pregnancy
Q&A: New Trials Tackle COVID-19 Vaccines in Pregnancy
Catherine Shaffer | Feb 25, 2021
Geeta Swamy of Duke University School of Medicine speaks with The Scientist about starting what she considers a long-overdue clinical study of COVID-19 vaccines in pregnant women.
COVID-19 Vaccines for Pregnant Moms May Protect Newborns
COVID-19 Vaccines for Pregnant Moms May Protect Newborns
Catherine Shaffer | Feb 17, 2021
A case study finds SARS-CoV-2 antibodies in placental cord blood after maternal vaccination.
COVID-19 More Deadly with Blood than Solid Cancer: Study
COVID-19 More Deadly with Blood than Solid Cancer: Study
Marcus A. Banks | Feb 16, 2021
Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
Abby Olena | Feb 16, 2021
Researchers identify deletions in the N-terminal domain of the spike protein that allow the coronavirus to avoid antibody neutralization and that may contribute to the emergence of new variants.
Vaccines Versus the Mutants
Vaccines Versus the Mutants
Anthony King | Feb 8, 2021
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Chris Baraniuk | Feb 4, 2021
With many millions of people waiting several weeks to receive a second COVID-19 vaccine dose in some countries, experts consider the possibility that SARS-CoV-2 could evolve vaccine resistance.